HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Germana Bancone Selected Research

tafenoquine

1/2019Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion.
1/2019Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
3/2018Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.
1/2018Implications of current therapeutic restrictions for primaquine and tafenoquine in the radical cure of vivax malaria.
1/2018Point-of-Care Testing for G6PD Deficiency: Opportunities for Screening.
9/2017Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency (G6PD Mahidol Variant) versus G6PD-Normal Volunteers.
2/2017Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
1/2017The G6PD flow-cytometric assay is a reliable tool for diagnosis of G6PD deficiency in women and anaemic subjects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Germana Bancone Research Topics

Disease

32Glucosephosphate Dehydrogenase Deficiency
01/2021 - 01/2008
31Hemolysis
01/2021 - 01/2008
19Vivax Malaria
10/2021 - 01/2014
18Malaria
10/2021 - 10/2007
6Infections
01/2019 - 12/2010
3Neonatal Hyperbilirubinemia
01/2018 - 01/2018
2Inborn Genetic Diseases (Disease, Hereditary)
01/2020 - 01/2018
2Kernicterus
01/2019 - 01/2018
2Parasitemia
01/2019 - 10/2018
2Falciparum Malaria (Plasmodium falciparum Malaria)
01/2016 - 12/2014
1Favism
01/2021
1Jaundice (Icterus)
01/2018
1Typhoid Fever (Typhoid)
01/2018

Drug/Important Bio-Agent (IBA)

29Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA
01/2021 - 01/2008
27PrimaquineFDA Link
01/2021 - 12/2010
10Pharmaceutical PreparationsIBA
01/2021 - 01/2008
8tafenoquineIBA
01/2019 - 01/2017
7Chloroquine (Aralen)FDA LinkGeneric
10/2021 - 02/2017
78-aminoquinolineIBA
01/2018 - 03/2013
6Antimalarials (Antimalarial Agents)IBA
10/2021 - 01/2014
6EnzymesIBA
01/2021 - 01/2008
3artenimol (dihydroartemisinin)IBA
10/2021 - 02/2017
3piperaquineIBA
10/2021 - 02/2017
3DapsoneFDA Link
03/2018 - 01/2008
3Oxidants (Oxidizing Agents)IBA
01/2018 - 01/2008
2ArtesunateIBA
10/2021 - 10/2018
2AntigensIBA
01/2008 - 10/2007
1Lumefantrine Drug Combination Artemether (Coartem)FDA Link
10/2021
1Mefloquine (Lariam)FDA LinkGeneric
10/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
11/2020
1BilirubinIBA
01/2018
1Hemoglobins (Hemoglobin)IBA
12/2017
1NADP (NADPH)IBA
02/2017
1Transforming Growth Factor beta (TGF-beta)IBA
01/2008
1Complementary DNA (cDNA)IBA
01/2008
1ChemokinesIBA
01/2008
1RNA (Ribonucleic Acid)IBA
01/2008
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2008
1Recombinant ProteinsIBA
10/2007
1Immunoglobulin G (IgG)IBA
10/2007

Therapy/Procedure

2Therapeutics
01/2021 - 01/2019
1Duration of Therapy
01/2019
1Secondary Prevention
01/2019
1Prenatal Care (Care, Prenatal)
01/2017
1Blood Transfusion (Blood Transfusions)
01/2008